CardiologyHeart pill eases symptoms in thickened hearts without a blockage
Aficamten met both main goals in the ACACIA-HCM trial, modestly improving symptoms and exercise capacity in nonobstructive hypertrophic cardiomyopathy, a condition with no targeted treatment.
28 August 2026